European Non-interventional Study on Refractory Epilepsy With Developmental Delay
NCT04398667 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 93
Last updated 2023-12-01
Summary
This is a multinational, multicentre, non-interventional, retrospective data collection (manual Medical Chart Review).
Conditions
- Refractory Epilepsy
- Development Delay
Sponsors & Collaborators
-
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc.
collaborator INDUSTRY -
Zogenix, Inc.
lead INDUSTRY
Eligibility
- Min Age
- 2 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-14
- Primary Completion
- 2020-09-04
- Completion
- 2020-09-04
Countries
- France
- Germany
- Italy
- Spain
Study Locations
More Related Trials
-
Pathophysiology Based Therapy of Early Onset Epileptic Encephalopathies
NCT02968966 ·Status: WITHDRAWN ·Phase: PHASE2
-
Genetic and Electrophysiologic Study in Focal Drug-resistant Epilepsies
NCT02890641 ·Status: RECRUITING
-
Study of Antiepileptic Drug Effects on Child Development
NCT00353886 ·Status: COMPLETED
-
Biology of Juvenile Myoclonic Epilepsy
NCT03400371 ·Status: RECRUITING
-
A Prospective, Remote Observational Study in Pediatric Participants With Early-Onset SCN2A-Developmental and Epileptic Encephalopathy
NCT05407727 ·Status: COMPLETED
-
XEN496 (Ezogabine) in Children With KCNQ2 Developmental and Epileptic Encephalopathy
NCT04639310 ·Status: TERMINATED ·Phase: PHASE3
-
Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy
NCT04311242 ·Status: WITHDRAWN
-
Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
NCT05772429 ·Status: ACTIVE_NOT_RECRUITING
-
Study in Pediatric Subjects With Epilepsy
NCT01494584 ·Status: TERMINATED ·Phase: PHASE2
-
Study to Evaluate NBI-921352 as Adjunctive Therapy in Subjects With SCN8A Developmental and Epileptic Encephalopathy Syndrome (SCN8A-DEE)
NCT04873869 ·Status: TERMINATED ·Phase: PHASE2
-
Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD)
NCT01730170 ·Status: COMPLETED
-
Genetic Basis of Idiopathic Focal Epilepsies With Cognitif Deficits
NCT00851331 ·Status: UNKNOWN ·Phase: NA
-
A Study to Gather Information About Overall Occurrence and New Cases of Dravet and Lennox-Gastaut Syndromes in Children, Teenagers and Adults in Spain
NCT05982717 ·Status: COMPLETED
-
A Study of Lu AG06466 in Participants With Treatment Resistant Focal Epilepsy
NCT05081518 ·Status: TERMINATED ·Phase: PHASE1
-
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
NCT05126914 ·Status: RECRUITING
-
A Study of Soticlestat as an Add-on Therapy in Children and Adults With Dravet Syndrome or Lennox-Gastaut Syndrome
NCT05163314 ·Status: TERMINATED ·Phase: PHASE3
-
Cardiovascular Risk Reduction in Epilepsy
NCT05704439 ·Status: WITHDRAWN ·Phase: NA
-
Phenylbutyrate for Monogenetic Developmental and Epileptic Encephalopathy
NCT04937062 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1
-
A Study on Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS) in Children, Teenagers and Adults in Portugal
NCT06395792 ·Status: WITHDRAWN
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)
NCT06660394 ·Status: RECRUITING ·Phase: PHASE3
-
Birth Defects Associated With Exposure to Lamotrigine in Pregnancy (EUROCAT)
NCT01055327 ·Status: COMPLETED
-
Novel Network Analysis of Intracranial Stereoelectroencephalography
NCT03916848 ·Status: UNKNOWN ·Phase: NA
-
Human Epilepsy Project 3
NCT05374928 ·Status: ACTIVE_NOT_RECRUITING
-
An Open-Label Extension of the Study XEN496 (Ezogabine) in Children With KCNQ2-DEE
NCT04912856 ·Status: TERMINATED ·Phase: PHASE3